Effectiveness of planned health teaching on knowledge regarding anticoagulant therapy among patients receiving anticoagulant therapy at selected hospitals of city

INTRODUCTION:The Purpose of the study was The most frequently given medications for controlling blood coagulation in patients with AF, rheumatic valvular illness, heart valve replacement (HVR), Deep vein thrombosis (DVT), pulmonary embolism, and following orthopedic surgery are vitamin K antagonists like warfarin, Acenocoumarol, etc. In the US, warfarin is a highly common medication prescribed, however in India, acenocoumarol is the preferred medication.1The most frequent cause of death is venous thromboembolism, which affects roughly 3% of people with deep vein thrombosis (DVT) and 15% of those with pulmonary embolism. Statistics from the Centers for Disease Control and Prevention (CDC) show that 10 to 30 percent of patients pass away within a month of being diagnosed.5The most significant side effect of oral anticoagulation (OAC) with vitamin K antagonists is bleeding. While bleeding is inescapably associated with OAC, it may significantly affect the prognosis of treated subjects by resulting in treatment termination, lifelong impairment, or death. The annual incidence of significant bleeding, fatal hemorrhage, and cerebral bleeding during OAC is 2%–5%, 0.5%–1%, and 0.2%–0.4%, respectively.7In general practice, oral anticoagulation therapy (OAT) presents a problem, particularly for high-risk populations like the elderly. One of the main causes of difficulties is thought to be a lack of patient education regarding OAT safety-relevant issues